DG Comp charges Lundbeck over pay-for-delay
Stefano Berra • Wednesday, 25 July 2012 (9 months ago)
The European Commission has charged pharmaceutical company Lundbeck over patent settlements with generic drug makers that allegedly delayed the entry of generic products to the market, and is set to charge Servier over similar allegations.
Subscription required to view this article
This content can only be accessed by subscribers.
Please note: If you would like online access to all archived content, you will need a subscription with premium access.
Please see Subscriptions.
If you are a subscriber, please login: